BioXcel LLC 13D and 13G filings for BioXcel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-06-06 8:29 pm Sale |
2024-06-06 | 13D | BioXcel Therapeutics, Inc. BTAI |
BioXcel LLC | 551,914 23.500% |
-42,126 (-7.09%) |
Filing |
| 2023-09-28 5:00 pm Sale |
2023-09-19 | 13D | BioXcel Therapeutics, Inc. BTAI |
BioXcel LLC | 594,040 32.500% |
-15,823 (-2.59%) |
Filing |
| 2020-05-13 7:20 pm Purchase |
2018-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
BioXcel LLC | 609,863 48.300% |
17,300 (+2.92%) |
Filing |